Citizens Memorial’s Post

As medical professionals dedicated to neurological research and patient care, understanding the intricate role of white matter in neuronal signaling is pivotal. It not only bridges communication between gray matter areas but also holds significant implications for conditions like ALSP. Let's continue to deepen our knowledge in pursuit of breakthrough treatments. #RareDisease #NeurologicalResearch #WhiteMatter

💻 WEBINAR | Join The Geriatric Emergency Department Collaborative for their webinar on Monday, March 25 at 3pm ET, "A Guide to Amyloid-Related Imaging (ARIA) Abnormalities in Alzheimer's Disease." Learn about emergency medicine clinicians' role in the recognition and acute management of ARIA, including how ARIA may present & what courses of action are needed for different severities: https://ow.ly/LhVS50QSy2i Co-hosted with Efficient CME

💻 WEBINAR | TODAY: Join The Geriatric Emergency Department Collaborative for their webinar on Monday, March 25 at 3pm ET, "A Guide to Amyloid-Related Imaging (ARIA) Abnormalities in Alzheimer's Disease." Learn about emergency medicine clinicians' role in the recognition and acute management of ARIA, including how ARIA may present & what courses of action are needed for different severities: https://ow.ly/LhVS50QSy2i Co-hosted with Efficient CME

Meet Michael and Suzanne O'Brien from South Florida. In this series, "The Participant's Perspective on Clinical Research," Mike and Suzanne share their experience with dementia clinical research at JEM Research Institute, a Headlands Research clinical trial site. In the second video, Mike and Suzanne share the conversation they had with neurologist, Dr. James Goldenberg, that ultimately led them to participate in clinical research at JEM Research Institute. #HeadlandsResearch #ClinicalTrials #ALZresearch #ClinicalTrialSites

In case you missed it, here's Part 2 of our interview with Mercy neurologist Dr. Howie Zheng and Jocelyn Henning, PA, Director, Mercy Stroke Program, on the latest edition of #MEDOSCOPY:

Here is a thought leadership pill after a hot summer: Aug 30 "Straight Talk" with Rene Stephens, MSHS about the importance of cost benchmarking during the outsourcing process. Sign in to attend here: https://lnkd.in/dMZskmKw Read my blog on the theme for additional clinical outsourcing brain stimulation- https://lnkd.in/d2iNBe4f, and send us your thoughts at [email protected].

Whether it’s an excuse for mid-morning coffee, lunch at your desk or just listening to something different on your commute home, join us August 30th, and hear these two seasoned professionals talk about how important cost benchmarking can be in the outsourcing process.

“As a neurologist, a clinical researcher and someone who has seen Alzheimer’s in my own family, I’m grateful we are seeing such progress in our field. But, Abby, we need help from your readers to test these promising medications before the devastating symptoms of Alzheimer’s disease are apparent.” In a letter to Dear Abby, Reisa Sperling, M.D., a professor at Harvard Medical School, stresses the importance of clinical trial participation. Abby encourages readers to enroll in TrialMatch, our free clinical trial matching service. Read the letter at https://bit.ly/3v2oukr and learn more about TrialMatch at alz.org/TrialMatch.

“As a neurologist, a clinical researcher and someone who has seen Alzheimer’s in my own family, I’m grateful we are seeing such progress in our field. But, Abby, we need help from your readers to test these promising medications before the devastating symptoms of Alzheimer’s disease are apparent.” In a letter to Dear Abby, Reisa Sperling, M.D., a professor at Harvard Medical School, stresses the importance of clinical trial participation. Abby encourages readers to enroll in TrialMatch, our free clinical trial matching service. Read the letter at https://bit.ly/3v2oukr and learn more about TrialMatch at alz.org/TrialMatch.

“As a neurologist, a clinical researcher and someone who has seen Alzheimer’s in my own family, I’m grateful we are seeing such progress in our field. But, Abby, we need help from your readers to test these promising medications before the devastating symptoms of Alzheimer’s disease are apparent.” In a letter to Dear Abby, Reisa Sperling, M.D., a professor at Harvard Medical School, stresses the importance of clinical trial participation. Abby encourages readers to enroll in TrialMatch, our free clinical trial matching service. Read the letter at https://bit.ly/3v2oukr and learn more about TrialMatch at alz.org/TrialMatch.